Single-dose treatment of acute cystitis with fosfomycin tromethamine

Annals of Pharmacotherapy

Volumn 32, Issue 2, 1998, Pages 215-219

  Stein, Gary E ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Acute cystitis; Fosfomycin tromethamine

Indexed keywords

FOSFOMYCIN TROMETAMOL;

ANGIONEUROTIC EDEMA; ANTIBACTERIAL ACTIVITY; APLASTIC ANEMIA; CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DYSPEPSIA; HEADACHE; HUMAN; NAUSEA; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; VERTIGO; VOMITING;

ACUTE DISEASE; ADULT; AGED; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; CYSTITIS; FEMALE; FOSFOMYCIN; HUMANS; MIDDLE AGED; PREGNANCY;

EID: 0031893912     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.17227     Document Type: Review

References (33)

1. Kahan FM, Kahan JS, Cassidy JP, Kropp H. The mechanisms of action of fosfomycin. Ann N Y Acad Sci 1974;235:364-86.
2. Barry AL, Fuchs PC. In vitro susceptibility testing procedures for fosfomycin tromethamine. Antimicrob Agents Chemother 1991;35:1235-8.
3. Barry AL, Brown SD. Antibacterial spectrum of fosfomycin trometamol. J Antimicrob Chemother 1995;35:228-30.
4. Cornaglia G, Pompei R, Foddis G, Satta G. Antibacterial activity of fosfomycin trometamol in an in vitro model of the urinary bladder. In: Neu HC, Williams JD, eds. New trends in urinary tract infections. Basel, Switzerland: Karger, 1988:255-60.
5. Kadner RJ, Winkler HH. Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J Bacteriol 1973;113:895-900.
6. Arca P, Hardisson C, Suarez JE. Purification of a glutathione S-transferase that mediates resistance in bacteria. Antimicrob Agents Chemother 1990;34:844-8.
7. Lerner SA, Price S, Kulkarni S. Microbiological studies of fosfomycin trometamol against urinary isolate in vitro. In: Neu HC, Williams JD, eds. New trends in urinary tract infections. Basel, Switzerland: Karger, 1988:121-9.
8. Greenwood D. Activity of the trometamol salt of fosfomycin in an in vitro model of the treatment of bacterial cystitis. Infection 1986;14:186-9.
9. Greenwood D, Edwards R, Brown J, Ridout P. The comparative activity of fosfomycin trometamol against organisms isolated from infected urines. Infection 1992;20(suppl 4):302-4.
10. Bergan T. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity. Infection 1990; 18(suppl 2):65-9.
11. Reeves DS. Fosfomycin trometamol. J Antimicrob Chemother 1994; 34:853-8.
12. Bergan T. Pharmacokinetics of fosfomycin. Rev Contemp Pharmacother 1995;6:55-62.
13. Ferreres L, Paz M, Martin G, Gobernado M. New studies on placental transfer of fosfomycin. Chemotherapy 1977;23(suppl 1):175-9.
14. Fillastre JP, Leroy A, Humbert G, Borsa F, Josse S. Comparative pharmacokinetics of fosfomycin trometamol versus calcium fosfomycin in elderly subjects and uraemic patients. In: Neu HC, Williams JD, eds. New trends in urinary tract infections. Basel, Switzerland: Karger, 1988: 143-56.
15. Kirby WMM. Pharmacokinetics of fosfomycin. Chemotherapy 1977;23 (suppl 1):141-51.
16. Ragni N, Pivetta C, Paccagnella F, Foglia G, Del Bono GP, Fontana P. Urinary tract infections in pregnancy. In: Neu HC, Williams JD, eds. New trends in urinary tract infections. Basel, Switzerland: Karger, 1988: 197-206.
17. Careddu P, Borzani M, Varotto F, Garlaschi L, Fontana P. Trometamol salt of fosfomycin (Monuril). Eur Urol 1987;13(suppl 1):114-8.
18. Borgia M, Longo A, Lodola E. Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal. Int J Clin Pharmacol Ther Toxicol 1989;27:411-7.
19. Package insert. Monurol (fosfomycin tromethamine). St. Louis: Forest Laboratories, Inc., 1997.
20. Bergan T, Mastropaolo G, DiMario F, Naccarato R. Pharmacokinetics of fosfomycin and influence of cimetidine and metoclopramide on the bioavailability of fosfomycin trometamol. In: Neu HC, Williams JD, eds. New trends in urinary tract infections. Basel, Switzerland: Karger, 1988: 157-66.
21. Reeves DS. Clinical efficacy and safety of fosfomycin trometamol in the prevention and treatment of urinary tract infections. Rev Contemp Pharmacother 1995;6:71-83.
22. Boerema JBJ, Williams FTC. Fosfomycin trometamol in single dose versus norfloxacin for seven days in treatment of uncomplicated urinary infections in general practice. Infection 1990;18(suppl 2):S80-8.
23. Van Pienbroek E, Hermans J, Kaptein AA, Mulder JD. Fosfomycin trometamol in a single dose versus seven days of nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. Pharm World Sci 1993;61:257-62.
24. Selvaggi FP, Ditonno P, Traficante A, Battaglia M, DiLorenzo V. Fosfomycin trometamol versus norfloxacin in single dose for adult female uncomplicated UTIs. Chemotherapy 1990;36(suppl 1):31-3.
25. Harvard Davis R, O'Dowd TC, Holmes W, Smail J, Slack RCB. A comparative double-blind randomized study of single dose fosfomycin trometamol with trimethoprim in the treatment of uncomplicated urinary tract infections in general practice. Chemotherapy 1990;36(suppl 1):34-6.
26. Elhanan G, Tabenkin H, Yahalom R, Raz R. Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women. Antimicrob Agents Chemother 1994;38:2612-4.
27. Ferraro G, Ambrosi G, Bucci L, Palmieri R, Palmieri G. Fosfomycin trometamol versus norfloxacin in the treatment of uncomplicated lower urinary tract infections in the elderly. Chemotherapy 1990;36(suppl 1):46-9.
28. Palmieri G, Palmieri R, Ambrosi G, Bucci L, Agratti AM, Ferraro G. A new single-dose antibiotic in urinary tract infection in elderly patients. In: Neu HC, Williams JD, eds. New trends in urinary tract infections. Basel, Switzerland: Karger, 1988:322-4.
29. Naber KG. Fosfomycin trometamol in treatment of uncomplicated lower urinary tract infections in adult women - an overview. Infection 1992; 20(suppl 4):S310-1.
30. Naber KG, Johnson FN. The safety and tolerability of fosfomycin trometamol. Rev Contemp Pharmacother 1995;6:63-70.
31. Reeves DS. Treatment of bacteriuria in pregnancy with single dose fosfomycin trometamol: a review. Infection 1992;20(suppl 4):S313-6.
32. Medical Economics, 1997. Montvale, NJ.
33. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996;334:835-40.